Cargando…
Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis
PPARγ activators inhibit cancer cell growth. However the role of these agents in progression/metastasis is not well-defined. Using an orthotopic model of lung cancer, we showed that pioglitazone accelerated progression/metastasis through affects on macrophages. This suggests that potential therapeut...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382846/ https://www.ncbi.nlm.nih.gov/pubmed/22737631 http://dx.doi.org/10.4161/onci.19309 |